We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

19 hedge funds and large institutions have $56.9K invested in Coeptis Therapeutics Warrants in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

21% more capital invested

Capital invested by funds: $47K → $56.9K (+$9.92K)

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$1.78K
2
TSS
Two Sigma Securities
New York
+$992
3
WAM
Wolverine Asset Management
Illinois
+$40
4
CS
Clear Street
New York
+$15
5
Bank of America
Bank of America
North Carolina
+$12

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$1.74K
2
CL
CSS LLC
Illinois
-$1.37K
3
HF
HRT Financial
New York
-$80
4
UBS Group
UBS Group
Switzerland
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Ionic Capital Management
New York
$16.1K – – –
CF
2
Cantor Fitzgerald
New York
$12.8K – – –
RCM
3
Rivernorth Capital Management
Florida
$4.65K – – –
MC
4
Meteora Capital
Florida
$4.6K – – –
Walleye Capital
5
Walleye Capital
New York
$3.38K – – –
HF
6
HRT Financial
New York
$3K -$80 -2,048 -2%
CL
7
CSS LLC
Illinois
$2.41K -$1.37K -34,900 -47%
Walleye Trading
8
Walleye Trading
New York
$2.25K – – –
SIA
9
SkyView Investment Advisors
New Jersey
$2K – – –
CAC
10
Cowen and Company
New York
$1.41K +$1.78K +45,400 New
WAM
11
Wolverine Asset Management
Illinois
$1.04K +$40 +1,017 +3%
LCM
12
Landscape Capital Management
New Jersey
$993 – – –
SM
13
Skaana Management
New York
$905 – – –
TSS
14
Two Sigma Securities
New York
$782 +$992 +25,230 New
HHGC
15
Hunting Hill Global Capital
New York
$508 – – –
CS
16
Clear Street
New York
$62 +$15 +391 +24%
Bank of America
17
Bank of America
North Carolina
$16 +$12 +300 +150%
Wells Fargo
18
Wells Fargo
California
$12 +$12 +300 +300%
AA
19
AQR Arbitrage
Connecticut
– -$1.74K -45,745 Closed
UBS Group
20
UBS Group
Switzerland
– -$2 -100 Closed

COEPW Hedge Fund Activity: Q4 2023 in Review

19 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2023, worth a combined $56.9K — up 21% from $47K a quarter earlier.

Fund positioning in COEPW was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $1.78K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $1.74K sold.

  • 19 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $56.9K of Coeptis Therapeutics Warrants stock for Q4 2023, up 21% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q4 2023 and 2 closed out, a net change of 0 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q4 2023 was Cowen and Company, an estimated $1.78K added.
  • The largest Coeptis Therapeutics Warrants seller in Q4 2023 was AQR Arbitrage, an estimated $1.74K sold.

Based on aggregated 13F filings for Q4 2023.